Imago BioSciences, Inc. Common stock
IMGO
IMGO was delisted on the 10th of January, 2023.
39 hedge funds and large institutions have $473M invested in Imago BioSciences, Inc. Common stock in 2021 Q3 according to their latest regulatory filings, with 39 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Blackstone Inc
New York
|
+$72.4M |
| 2 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
+$64.8M |
| 3 |
FM
Frazier Management
Seattle,
Washington
|
+$63.8M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$57.3M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$47.3M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $112K | +$120K | +5,606 | New |
|
|
AIG
27
American International Group
New York
| $107K | +$115K | +5,336 | New |
|
28
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
| $106K | +$113K | +5,268 | New |
|
29
JP Morgan Chase
New York
| $75K | +$80.1K | +3,734 | New |
|
30
Morgan Stanley
New York
| $50K | +$53.6K | +2,497 | New |
|
|
SO
31
STRS Ohio
Columbus,
Ohio
| $44K | +$47.2K | +2,200 | New |
|
32
Citigroup
New York
| $30K | +$32.3K | +1,507 | New |
|
33
Royal Bank of Canada
Toronto,
Ontario, Canada
| $21K | +$23.3K | +1,088 | New |
|
34
UBS Group
Zurich,
Switzerland
| $19K | +$19.9K | +929 | New |
|
35
Bank of America
Charlotte,
North Carolina
| $18K | +$18.3K | +854 | New |
|
36
Legal & General Group
London,
United Kingdom
| $18K | +$19.5K | +909 | New |
|
|
AIP
37
Ameritas Investment Partners
Lincoln,
Nebraska
| $15K | +$16K | +747 | New |
|
|
TRCT
38
Tower Research Capital (TRC)
New York
| $9K | +$9.29K | +433 | New |
|
39
Wells Fargo
San Francisco,
California
| $1K | +$1.22K | +57 | New |
|
IMGO Hedge Fund Activity: Q3 2021 in Review
39 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Imago BioSciences, Inc. Common stock (IMGO) for Q3 2021, worth a combined $473M.
Buyers outnumbered sellers: 39 funds opened new IMGO positions and 0 closed out — a net gain of 39 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Blackstone Inc, opening a new position worth an estimated $72.4M.
- 39 institutional investors held Imago BioSciences, Inc. Common stock (IMGO) as of Q3 2021, up from 0 in Q2 2021.
- Funds reported $473M of Imago BioSciences, Inc. Common stock stock for Q3 2021.
- 39 funds opened new Imago BioSciences, Inc. Common stock positions in Q3 2021 and 0 closed out, a net change of +39 holders.
- The largest Imago BioSciences, Inc. Common stock buyer in Q3 2021 was Blackstone Inc, an estimated $72.4M added.
Based on aggregated 13F filings for Q3 2021.